James (Jim) Buchanan Camden focuses his practice on antitrust litigation, health care antitrust counseling and defending mergers and acquisitions before the US antitrust agencies.
Jim has represented health care providers in transactions, government investigations and litigation, and has extensive experience defending hospital mergers for the Federal Trade Commission (FTC) in administrative "Part III" litigation. He also has represented health insurance companies in government investigations. In addition, Jim has counseled clients in the defense and metal products industries. He also defended clients in litigation before the International Trade Commission (ITC) on claims related to patent misuse.
While in law school, Jim served as an associate editor for the Washington University Journal of Law & Policy. As a participant in Washington University Law's Congressional and Administrative Law Clinic, he interned in the Office of Chairman Jon Leibowitz at the FTC, where he focused on issues related to pharmaceutical patent settlements involving brand-to-generic payments. Previously, Jim spent several months as a seconded associate with the general counsel of a Firm client, where he worked on various corporate and compliance matters.